L-829165 F-18

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596716

CAS#: 262598-99-2

Description: L-829165 F-18 is a Neurokinin-1 Receptor Antagonist.

Chemical Structure

L-829165 F-18
CAS# 262598-99-2

Theoretical Analysis

MedKoo Cat#: 596716
Name: L-829165 F-18
CAS#: 262598-99-2
Chemical Formula: C21H22F318FN6O
Exact Mass: 449.1817
Molecular Weight: 449.44
Elemental Analysis: C, 56.12; H, 4.93; F, 16.69; N, 18.70; O, 3.56

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: L-829165 F-18; L 829165 F-18; L829165 F-18; (18F)-SPA-RQ;

IUPAC/Chemical Name: (2S,3S)-N-(2-((fluoro-18F)methoxy)-5-(5-(trifluoromethyl)-1H-tetrazol-1-yl)benzyl)-2-phenylpiperidin-3-amine


InChi Code: InChI=1S/C21H22F4N6O/c22-13-32-18-9-8-16(31-20(21(23,24)25)28-29-30-31)11-15(18)12-27-17-7-4-10-26-19(17)14-5-2-1-3-6-14/h1-3,5-6,8-9,11,17,19,26-27H,4,7,10,12-13H2/t17-,19-/m0/s1/i22-1

SMILES Code: [18F]COc1c(CN[C@@H](CCCN2)[C@@H]2c3ccccc3)cc(n4nnnc4C(F)(F)F)cc1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 449.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Furumoto H, Shimada Y, Imai K, Maehara S, Maeda J, Hagiwara M, Okano T, Masuno R, Kakihana M, Kajiwara N, Ohira T, Ikeda N. Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung. Lung Cancer. 2018 Jul;121:91-96. doi: 10.1016/j.lungcan.2018.05.001. Epub 2018 May 4. PubMed PMID: 29858033.

2: Yu KJ, Lee BJ, Han J, Park D. Usefulness of F-18 FP-CIT PET to predict dopamine-responsive hand tremor in patients other than Parkinson's disease: Two case reports. Medicine (Baltimore). 2018 Jun;97(22):e10983. doi: 10.1097/MD.0000000000010983. PubMed PMID: 29851853.

3: Ha HK, Koo PJ, Kim SJ. Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis. Oncology. 2018 May 30;95(1):31-38. doi: 10.1159/000488200. [Epub ahead of print] PubMed PMID: 29847834.

4: Cengiz A, Arda HÜ, Döğer F, Yavaşoğlu İ, Yürekli Y, Bolaman AZ. Correlation between baseline 18F-FDG PET/CT findings and CD38, CD138 expressing myeloma cells in bone marrow and clinical parameters in patiens with multiple myeloma. Turk J Haematol. 2018 May 28. doi: 10.4274/tjh.2017.0372. [Epub ahead of print] PubMed PMID: 29806594.

5: Yan F, Li J, Wang HJ, Yang X, Yang JB, Tu XJ. [Impacts of different methods in laryngeal mask airway positioning on the airway management of elderly patients with general anesthesia]. Zhonghua Yi Xue Za Zhi. 2018 May 15;98(18):1424-1429. doi: 10.3760/cma.j.issn.0376-2491.2018.18.011. Chinese. PubMed PMID: 29804406.

6: Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, Høgh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment. JAMA Neurol. 2018 May 14. doi: 10.1001/jamaneurol.2018.0894. [Epub ahead of print] PubMed PMID: 29799984.

7: Parsons S, Thomson W, Cresswell K, Starling B, McDonagh JE; Barbara Ansell National Network for Adolescent Rheumatology (BANNAR). What do young people with rheumatic conditions in the UK think about research involvement? A qualitative study. Pediatr Rheumatol Online J. 2018 May 24;16(1):35. doi: 10.1186/s12969-018-0251-z. PubMed PMID: 29793489; PubMed Central PMCID: PMC5968709.

8: Sun X, Li C, Cao Y, Shi X, Li L, Zhang W, Wu X, Wu N, Jing H, Zhang W. F-18 FDG PET/CT in 26 patients with SAPHO syndrome: a new vision of clinical and bone scintigraphy correlation. J Orthop Surg Res. 2018 May 22;13(1):120. doi: 10.1186/s13018-018-0795-0. PubMed PMID: 29788984; PubMed Central PMCID: PMC5964683.

9: Woo SK, Moon BS, Kim BS, Kim MH, Lee YJ, Jung JH, Lee KC, Seo Y, Kim W, Lim SM, Lee BC, Kim SE. Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[(18)F]fluoropropyl)benzylguanidine ([(18)F]mFPBG). Nucl Med Biol. 2018 May 3;61:63-70. doi: 10.1016/j.nucmedbio.2018.04.005. [Epub ahead of print] PubMed PMID: 29783202.

10: Schwarz AJ, Shcherbinin S, Slieker LJ, Risacher SL, Charil A, Irizarry MC, Fleisher AS, Southekal S, Joshi AD, Devous MD Sr, Miller BB, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative. Topographic staging of tau positron emission tomography images. Alzheimers Dement (Amst). 2018 Feb 14;10:221-231. doi: 10.1016/j.dadm.2018.01.006. eCollection 2018. PubMed PMID: 29780867; PubMed Central PMCID: PMC5956800.

11: Park JW, Kim YI, Kang HG, Kim JH, Kim HS. Joint-preserving palliative surgery using self-locking screws of intramedullary nail and percutaneous cementoplasty for proximal humeral metastasis in the advanced cancer patients. World J Surg Oncol. 2018 May 15;16(1):93. doi: 10.1186/s12957-018-1397-3. PubMed PMID: 29764470; PubMed Central PMCID: PMC5952846.

12: Lee JW, Lee HS, Na JO, Lee SM. Effect of adipose tissue volume on prognosis in patients with non-small cell lung cancer. Clin Imaging. 2018 May 4;50:308-313. doi: 10.1016/j.clinimag.2018.05.006. [Epub ahead of print] PubMed PMID: 29751203.

13: Sah BR, Leissing CA, Delso G, Ter Voert EE, Krieg S, Leibl S, Schneider PM, Reiner CS, Hüllner MW, Veit-Haibach P. Evaluation of multifunctional imaging parameters in gastro-oesophageal cancer using F-18-FDG-PET/CT with integrated perfusion CT. Q J Nucl Med Mol Imaging. 2018 May 10. doi: 10.23736/S1824-4785.18.03067-4. [Epub ahead of print] PubMed PMID: 29745630.

14: Beinat C, Haywood T, Chen YS, Patel CB, Alam IS, Murty S, Gambhir SS. The Utility of [(18)F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography. Mol Imaging Biol. 2018 May 7. doi: 10.1007/s11307-018-1194-y. [Epub ahead of print] PubMed PMID: 29736561.

15: Rogasch JMM, Hundsdoerfer P, Hofheinz F, Wedel F, Schatka I, Amthauer H, Furth C. Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma. BMC Cancer. 2018 May 3;18(1):521. doi: 10.1186/s12885-018-4432-4. PubMed PMID: 29724189; PubMed Central PMCID: PMC5934894.

16: Cuccurullo V, Di Stasio GD, Mansi L. Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers. World J Nucl Med. 2018 Apr-Jun;17(2):70-78. doi: 10.4103/wjnm.WJNM_54_17. Review. PubMed PMID: 29719480; PubMed Central PMCID: PMC5905261.

17: Zhang C, Zhang Z, Lin KS, Lau J, Zeisler J, Colpo N, Perrin DM, Bénard F. Melanoma Imaging Using (18)F-Labeled α-Melanocyte-Stimulating Hormone Derivatives with Positron Emission Tomography. Mol Pharm. 2018 Jun 4;15(6):2116-2122. doi: 10.1021/acs.molpharmaceut.7b01113. Epub 2018 May 10. PubMed PMID: 29714486.

18: Koç ZP, Kara PÖ, Dağtekin A. Detection of unknown primary tumor in patients presented with brain metastasis by F-18 fluorodeoxyglucose positron emission tomography/computed tomography. CNS Oncol. 2018 Apr;7(2):CNS12. doi: 10.2217/cns-2017-0018. Epub 2018 Apr 30. PubMed PMID: 29708403; PubMed Central PMCID: PMC5977273.

19: Lee Y, Kroemer NB, Oehme L, Beuthien-Baumann B, Goschke T, Smolka MN. Lower dopamine tone in the striatum is associated with higher body mass index. Eur Neuropsychopharmacol. 2018 Apr 25. pii: S0924-977X(18)30072-5. doi: 10.1016/j.euroneuro.2018.03.009. [Epub ahead of print] PubMed PMID: 29705023.

20: Loewenstein DA, Curiel RE, Rosselli M, Penate A, Greig-Custo MT, Bauer RM, Guinjoan SM, Hanson KS, Li C, Lizarraga G, Barker WW, Torres V, DeKosky S, Adjouadi M, Duara R. Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness. Curr Alzheimer Res. 2018 Apr 27. doi: 10.2174/1567205015666180427122746. [Epub ahead of print] PubMed PMID: 29701153.